Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-025892
Filing Date
2025-02-24
Accepted
2025-02-24 18:47:18
Documents
2
Period of Report
2025-02-20

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2853
2 EX-24 avir-ex24.htm EX-24 15864
  Complete submission text file 0000950170-25-025892.txt   20200
Mailing Address 7100 WEST CREDIT AVENUE, SUITE 101 C/O ARALEZ PHARMACEUTICALS INC. MISSISSAUGA A6 L5N 0E4
Business Address
Kirsch Arthur S (Reporting) CIK: 0001290976 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39661 | Film No.: 25658673

Mailing Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110
Business Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Issuer) CIK: 0001593899 (see all company filings)

EIN.: 460574869 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)